Results 101 to 110 of about 2,934 (153)

Carotidynia - An Unexplored Entity in Otolaryngology Practice: Three Case Reports & Review of Literature. [PDF]

Indian J Otolaryngol Head Neck Surg
Sharma R, Kumar P, Singh D, Meher R, Kumar J.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

METHYSERGIDE IN MANIA

Lancet, The, 1969
exaly   +13 more sources

METHYSERGIDE AND RETROPERITONEAL FIBROSIS

Lancet, The, 1987
exaly   +7 more sources

METHYSERGIDE AND CORONARY-ARTERY DISEASE

Lancet, The, 1967
P, Hudgson, J B, Foster, J N, Walton
exaly   +3 more sources

Methysergide

Cephalalgia, 1998
Methysergide is a semisynthetic ergot alkaloid ergometrine derivative, introduced in pharmacotherapy for migraine prophylaxis as a specific serotonin (5HT) receptor antagonist. Methysergide is not just a 5HT2 antagonist, it is also a 5HT1 agonist. Open and controlled studies attest to methysergide's efficacy. It may be more effective in resistant cases
openaire   +2 more sources

METHYSERGIDE IN MANIA

The Lancet, 1968
I HAVE proposed a comprehensive theory of cerebral amine function which links biochemical, physiological, psychological and clinical phenomena1,2. One hypothesis derived from this general theory is that methysergide should benefit patients with mania. The results of trials in the first five patients are sufficiently notable for a preliminary account to
openaire   +3 more sources

Methysergide in migraine prophylaxis

Clinical Pharmacology & Therapeutics, 1966
In a clinical trial, methysergide and placebo were compared by the double‐blind method. The study was arranged so that it was also possible to assess the effect of methysergide and that of placebo in relation to the pre‐experimental condition. A dose of 6 mg. of methysergide was given to adult patients daily.
E, Pedersen, C E, Moller
openaire   +2 more sources

Methysergide

The Practitioner, 1967
D. A. Curran, H. Hinterberger, J. W. Lance   +2 more
  +6 more sources